Metsä Board Oyj (METSA.HE)

Negative revenue growth while VALMT.HE stands at 4.81%. Joel Greenblatt would look for strategic missteps or cyclical reasons.

Negative gross profit growth while VALMT.HE is at 2.93%. Joel Greenblatt would examine cost competitiveness or demand decline.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.

Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.

Share count expansion well above VALMT.HE's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.

Diluted share count expanding well above VALMT.HE's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.

Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.

Negative 10Y revenue/share CAGR while VALMT.HE stands at 29.63%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.

Negative 5Y CAGR while VALMT.HE stands at 11.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.

Negative 10Y OCF/share CAGR while VALMT.HE stands at 278.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.

Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.

Negative 3Y OCF/share CAGR while VALMT.HE stands at 192.67%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.

Negative 10Y net income/share CAGR while VALMT.HE is at 8.49%. Joel Greenblatt sees a major red flag in long-term profit erosion.

Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.

Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.

10Y equity/share CAGR at 50-75% of VALMT.HE's 139.36%. Martin Whitman would note a lag in capital accumulation vs. the competitor.

Below 50% of VALMT.HE's 103.25%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.

Negative 3Y equity/share growth while VALMT.HE is at 0.47%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.

Cut dividends over 10 years while VALMT.HE stands at 174.90%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.

Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.

Negative near-term dividend growth while VALMT.HE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.

Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.

Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.